| Combined treatment of sudden sensorineural hearing loss with steroid, dextran and piracetam: experience with 68 cases. | |
| | |
MedLine Citation:
|
PMID: 12937918 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The purpose of this study was to evaluate the effectiveness of our combined treatment regimen and to clarify the possible prognostic factors in sudden sensorineural hearing loss (SSNHL). In a retrospective chart review, the charts of 68 patients who matched the inclusion criteria of this study were evaluated. All patients were treated with a standard regimen including prednisone, dextran and piracetam between January 1998 and December 2001. Initial (at the beginning of therapy) and final (3 weeks after the beginning of therapy) audiograms were compared with respect to hearing improvement. Possible prognostic factors were also evaluated. Overall hearing improvement was determined as 54.4%. Sex was the only determined prognostic factor in this study. Females had a better prognosis. Our treatment regimen had no superiority to the reported spontaneous hearing recovery. Females seem to have a better prognosis. |
| | |
Authors:
|
Erdal Samim; Rahmi Kilic; Ali Ozdek; Hakan Gocmen; Adil Eryilmaz; Ilhan Unlu |
Related Documents
:
|
17016718 - Histopathologic indicators of recurrence in meningiomas: correlation with clinical and ... 23397588 - Outcomes after interdisciplinary management of 7 patients with askin tumor. 19752758 - Prognostic factors according to the treatment schedule in malignant pleural mesothelioma. 19785768 - A proposed prognostic 7-day survival formula for patients with terminal cancer. 16516128 - New agents for the treatment of acute myeloid leukemia. 12212588 - Carcinoma of the nasopharynx: analysis of treatment results in 91 patients. |
Publication Detail:
|
Type: Journal Article Date: 2003-08-22 |
Journal Detail:
|
Title: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery Volume: 261 ISSN: 0937-4477 ISO Abbreviation: Eur Arch Otorhinolaryngol Publication Date: 2004 Apr |
Date Detail:
|
Created Date: 2004-04-22 Completed Date: 2004-09-22 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 9002937 Medline TA: Eur Arch Otorhinolaryngol Country: Germany |
Other Details:
|
Languages: eng Pagination: 187-90 Citation Subset: IM |
Affiliation:
|
Department of Ear, Nose and Throat, Ministry of Health Research and Training Hospital, Ankara, Turkey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Administration, Oral Adolescent Adult Age Factors Aged Aged, 80 and over Audiometry Child Dextrans / administration & dosage* Dose-Response Relationship, Drug Drug Administration Schedule Drug Therapy, Combination Female Follow-Up Studies Hearing Loss, Sensorineural / diagnosis, drug therapy* Hearing Loss, Sudden / diagnosis, drug therapy* Humans Infusions, Intravenous Male Middle Aged Piracetam / administration & dosage* Prednisone / administration & dosage* Probability Retrospective Studies Risk Assessment Severity of Illness Index Sex Factors Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
53-03-2/Prednisone; 7491-74-9/Piracetam; 9004-54-0/Dextrans |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Multiple system atrophy manifested as dizziness and imbalance: a report of two cases.
Next Document: Postarthroplasty histiocytic lymphadenopathy in a patient with uterine carcinoma.